Multitarget Drug Discovery and Polypharmacology
ChemMedChem2016Vol. 11(12), pp. 1190–1192
Citations Over TimeTop 10% of 2016 papers
Abstract
Promising promiscuity: Guest editors Maria Laura Bolognesi and Andrea Cavalli set the stage for this ChemMedChem Special Issue on Polypharmacology and Multitarget Drugs. They highlight cases in which a departure from the "one target, one drug" paradigm has proven advantageous, with single molecules that can engage two or more targets to address a given pathology. Articles in this issue underscore the importance of focusing ever more attention to polypharmacology in drug discovery efforts.
Related Papers
- → In silico drug repositioning – what we need to know(2012)184 cited
- → Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents(2022)40 cited
- → Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing(2018)40 cited
- → Computational drug repurposing to predict approved and novel drug-disease associations(2018)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)